ملخص
During the past few decades the development of novel radiolabeled tracers and the improvement of instruments for imaging have enabled a functional approach to be taken based on metabolic alterations rather than physiological phenomena [1]. Positron emission tomography (PET) is a unique formof diagnostic imaging that observes in vivo biologic changes using radiopharmaceuticals that closely mimic endogenous molecules. It produces images of the concentration of a radioactive tracer in the body, which has been selected to represent the specific metabolic process under study. PET studies consist of a series of consecutive PET images and contain information about the temporal evolution of the radiotracer concentration. 18-Fluorodeoxyglucose (18F-FDG) is considered the current ideal radiopharmaceutical for PET imaging owing to its low positron energy (0.64 MeV) of 18F, which results in a low radiation dose rate to the patient and also allows high resolution images [2]. It is the most commonly used tracer because of the practical half-life of 18F of 110 min, compared with other shorterlived positron emitters. 18F-FDG allows the evaluation of glucose metabolism in several disorders.
| اللغة الأصلية | English |
|---|---|
| عنوان منشور المضيف | The Pathophysiologic Basis of Nuclear Medicine |
| العنوان الفرعي لمنشور المضيف | Second Edition |
| ناشر | Springer Berlin Heidelberg |
| الصفحات | 50-66 |
| عدد الصفحات | 17 |
| رقم المعيار الدولي للكتب (المطبوع) | 3540239928, 9783540239925 |
| المعرِّفات الرقمية للأشياء | |
| حالة النشر | Published - 2006 |
بصمة
أدرس بدقة موضوعات البحث “Basis of 18F-FDG positron emission tomography imaging'. فهما يشكلان معًا بصمة فريدة.قم بذكر هذا
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver